You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Baxter
Harvard Business School
Johnson and Johnson
Express Scripts

Last Updated: May 24, 2020

DrugPatentWatch Database Preview

Patent: 10,577,154

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,577,154
Title:Passivation, pH protective or lubricity coating for pharmaceutical package, coating process and apparatus
Abstract: A method for providing a passivation layer or pH protective coating on a substrate surface by PECVD is provided, the method comprising generating a plasma from a gaseous reactant comprising polymerizing gases. The lubricity, passivation, pH protective, hydrophobicity, and/or barrier properties of the passivation layer or pH protective coating are set by setting the ratio of the O.sub.2 to the organosilicon precursor in the precursor feed, and/or by setting the electric power used for generating the plasma. In particular, a passivation layer or pH protective coating made by the method is provided. Pharmaceutical packages coated by the method and the use of such packages protecting composition contained in the vessel against mechanical and/or chemical effects of the surface of the package without a passivation layer or pH protective coating material are also provided.
Inventor(s): Felts; John T. (Alameda, CA), Fisk; Thomas E. (Green Valley, AZ), Abrams; Robert S. (Albany, NY), Ferguson; John (Auburn, AL), Freedman; Jonathan R. (Auburn, AL), Pangborn; Robert J. (Harbor Springs, MI), Sagona; Peter J. (Pottstown, PA), Weikart; Christopher (Auburn, AL)
Assignee: SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)
Application Number:16/226,463
Patent Claims:see list of patent claims

Details for Patent 10,577,154

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Wyeth Pharms Inc MYLOTARG gemtuzumab ozogamicin VIAL;SINGLE-DOSE 761060 001 2018-04-09   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2029-05-13 RX Orphan search
Genentech Inc OCREVUS ocrelizumab INJECTABLE;INJECTION 761053 001 2017-03-28   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2029-05-13 RX search
Janssen Biotech STELARA ustekinumab INJECTABLE;INJECTION 761044 001 2019-11-07   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2029-05-13 RX search
Biogen ZINBRYTA daclizumab INJECTABLE;INJECTION 761029 001 2017-05-26   Start Trial SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) 2029-05-13 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Dow
Moodys
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.